Rezolute (RZLT) Total Current Liabilities (2011 - 2026)
Rezolute recorded quarterly Total Current Liabilities of $7.7 million in Q1 2026, down 18.91% quarter-over-quarter from $9.5 million in Q4 2025, and down 26.82% year-over-year from $10.5 million in Q1 2025.
Rezolute's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $7.7 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 26.82% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $7.7 million (down 26.82% YoY), while the FY2025 annual figure was $11.9 million, up 24.01% from the prior year.
- Total Current Liabilities came in at $7.7 million for Q1 2026 at Rezolute, down from $9.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $11.9 million in Q2 2025 to a low of $2.4 million in Q3 2022.
- A 5-year average of $7.3 million and a median of $7.7 million in 2026 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities jumped 196.42% in 2023 and slipped 26.82% in 2026, its largest moves.
- Rezolute's Total Current Liabilities stood at $6.3 million in 2022, then gained by 27.11% to $8.0 million in 2023, then jumped by 32.47% to $10.6 million in 2024, then declined by 10.44% to $9.5 million in 2025, then dropped by 18.91% to $7.7 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $7.7 million, $9.5 million, and $10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | 7.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.70 Mn |
| Dec 31, 2025 | 9.50 Mn |
| Sep 30, 2025 | 10.21 Mn |
| Jun 30, 2025 | 11.91 Mn |
| Mar 31, 2025 | 10.53 Mn |
| Dec 31, 2024 | 10.61 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 9.61 Mn |
| Mar 31, 2024 | 6.96 Mn |
| Dec 31, 2023 | 8.01 Mn |
| Sep 30, 2023 | 7.20 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 4.40 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 2.43 Mn |
| Jun 30, 2022 | 2.46 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 6.40 Mn |
| Sep 30, 2021 | 2.60 Mn |
| Jun 30, 2021 | 1.97 Mn |
| Mar 31, 2021 | 3.59 Mn |
| Dec 31, 2020 | 2.74 Mn |
| Sep 30, 2020 | 2.92 Mn |
| Jun 30, 2020 | 3.23 Mn |
| Mar 31, 2020 | 3.53 Mn |
| Dec 31, 2019 | 5.54 Mn |
| Sep 30, 2019 | 5.52 Mn |
| Jun 30, 2019 | 8.38 Mn |
| Mar 31, 2019 | 6.62 Mn |
| Dec 31, 2018 | 2.98 Mn |
| Sep 30, 2018 | 7.34 Mn |
| Jun 30, 2018 | 6.25 Mn |
| Mar 31, 2018 | 4.37 Mn |
| Dec 31, 2017 | 2.25 Mn |
| Sep 30, 2017 | 1.69 Mn |
| Jun 30, 2017 | 1.77 Mn |
| Mar 31, 2017 | 2.02 Mn |
| Dec 31, 2016 | 1.67 Mn |
| Sep 30, 2016 | 1.49 Mn |
| Jun 30, 2016 | 1.73 Mn |
| Mar 31, 2016 | 2.42 Mn |
| Dec 31, 2015 | 2.49 Mn |
| Sep 30, 2015 | 1.96 Mn |
| Jun 30, 2015 | 1.71 Mn |
| Mar 31, 2015 | 1.80 Mn |
| Dec 31, 2014 | 2.37 Mn |
| Sep 30, 2014 | 892,908.00 |
| Jun 30, 2014 | 964,040.00 |
| Mar 31, 2014 | 2.86 Mn |
| Dec 31, 2013 | 6.54 Mn |
| Sep 30, 2013 | 5.68 Mn |
| Jun 30, 2013 | 5.27 Mn |
| Mar 31, 2013 | 5.12 Mn |
| Dec 31, 2012 | 24,470.00 |
| Sep 30, 2012 | 15,643.00 |
| Jun 30, 2012 | 2.36 Mn |
| Mar 31, 2012 | 8,852.00 |
| Dec 31, 2011 | 1.40 Mn |
| Sep 30, 2011 | 5,499.00 |
| Jun 30, 2011 | 11,657.00 |